Why do companies operating within the pharmaceutical and biotechnology companies typically sustain higher ROIC?

Why do companies operating within the pharmaceutical and biotechnology companies typically sustain higher ROIC’s than firms in the technology, hardware and equipment industries?What type of business, a software company or an electric utility, would benefit more from increasing ROIC than from increasing growth? Why?